# VERAPAMIL HCI

NDC: 51662-1269
Generic name: VERAPAMIL HCI
Labeler / Manufacturer: HF Acquisition Co LLC, DBA HealthFirst
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20180917

FDA application: ANDA070737

## Active ingredients

- VERAPAMIL HYDROCHLORIDE: 2.5 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51662-1269"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51662-1269
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=76112f5f-ce5d-ec60-e053-2a91aa0aae4e